Skip to content

Adaptation of Written Exposure Therapy in Substance Treatment

Treating OUD/PTSD in Residential Care: Written Exposure in Substance Treatment (WEST).

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07108608
Acronym
WEST
Enrollment
26
Registered
2025-08-07
Start date
2025-11-21
Completion date
2026-06-22
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder, Substance Use Disorders

Keywords

Written Exposure Therapy

Brief summary

The purpose of this pilot non-randomized, uncontrolled clinical trial is to test the feasibility and efficacy of written exposure therapy (WET) for posttraumatic stress disorder (PTSD) as adapted for use within the context of residential substance use disorder (SUD) treatment. All participants meet criteria for PTSD and are in a short term residential SUD treatment program (target residential treatment duration = 28 days) regardless of the research. The main question the study aims to answer is: 1) Is the delivery of adapted WET feasible and acceptable in short term residential SUD treatment for individuals with severe SUD?

Interventions

BEHAVIORALWritten Exposure Therapy

Written Exposure Therapy is a brief, evidenced based intervention for PTSD. WET is generally delivered individually across 5 sessions in which the therapist guides the patient through writing exercises. Across exposure sessions, participants experience habituation so that their symptoms decrease by the end of treatment. WET has an established evidence base in general outpatient psychotherapy for PTSD, but has not been adapted or tested in residential SUD treatment settings. Further, the investigators have adapted WET for this setting based on stakeholder and expert feedback.

BEHAVIORALTreatment as Usual

Treatment as Usual will include a variety of standard care services offered in short term residential treatment. For example, participants receiving TAU will participate in individual case management/general counseling sessions focused on substance use disorder and its consequences, group based psychoeducation sessions, group based counseling sessions (e.g., relapse prevention planning), individual services with a medical provider and pharmacotherapy (e.g., for withdrawal, relapse prevention, or co-occurring conditions)

Sponsors

Potomac Health Foundations
Lead SponsorOTHER
University of Maryland, Baltimore County
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Investigators are conducting an uncontrolled trial of approximately 20 subjects who will be assigned to adapted Written Exposure Therapy.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Enrolled in residential SUD treatment at MTC * Meet criteria for PTSD based on the Clinician-Administered PTSD Scale for DSM-5 * Be 18 years of age or older * Have sufficient memory of the index trauma to write about it * Be English speaking.

Exclusion criteria

* Inability to give informed consent for any reason (e.g., cognitive impairment) * Presence of acute psychosis or suicidality that would interfere with study participation * planning to leave residential treatment before WEST could realistically be completed as determined by the investigator

Design outcomes

Primary

MeasureTime frameDescription
PTSD symptom reductionPre-WEST intervention; post-WEST intervention (approximately 14 days after randomization, but will vary based on when participants complete the intervention); 4-weeks post enrollment; 8-weeks post enrollment; 12-weeks post enrollment.PTSD symptom reduction pre/post intervention by treatment arm as measured by the posttraumatic checklist for DSM-5 (PCL-5). The PCL-5 is a self-report questionnaire yielding scores ranging from 0-80 with higher scores indicating greater symptomology.

Secondary

MeasureTime frameDescription
Feasibility of WET delivered in residential SUD treatment contextUp to 4 weeks, or until the participant discharges from residential treatment (whichever comes first).Percentage of participants in the WET arm who were able to complete the treatment (5 sessions) prior to discharge
Acceptability of WET delivered in residential SUD treatment contextCollected post intervention window (approximately 3 weeks from enrollment)Treatment satisfaction scores among WET participants as measured by the 2-part credibility/expectancies questionnaire (CEQ). The CEQ utilizes two scoring systems that range from 1-9 or 0%-100%. with higher scores indicating greater acceptability.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026